- Home
- CVAC vs NVTS Comparison
CVAC vs NVTS Comparison
Compare CVAC & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- NVTS
- Stock Information
- Founded
- CVAC 2000
- NVTS 2014
- Country
- CVAC Germany
- NVTS United States
- Employees
- CVAC N/A
- NVTS N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- NVTS Semiconductors
- Sector
- CVAC Health Care
- NVTS Technology
- Exchange
- CVAC Nasdaq
- NVTS Nasdaq
- Market Cap
- CVAC 1.2B
- NVTS 1.3B
- IPO Year
- CVAC 2020
- NVTS N/A
- Fundamental
- Price
- CVAC $5.48
- NVTS $7.16
- Analyst Decision
- CVAC Hold
- NVTS Buy
- Analyst Count
- CVAC 3
- NVTS 7
- Target Price
- CVAC $6.83
- NVTS $4.93
- AVG Volume (30 Days)
- CVAC 789.9K
- NVTS 32.3M
- Earning Date
- CVAC 08-18-2025
- NVTS 08-04-2025
- Dividend Yield
- CVAC N/A
- NVTS N/A
- EPS Growth
- CVAC N/A
- NVTS N/A
- EPS
- CVAC 0.87
- NVTS N/A
- Revenue
- CVAC $566,039,775.00
- NVTS $68,167,000.00
- Revenue This Year
- CVAC N/A
- NVTS N/A
- Revenue Next Year
- CVAC $24.04
- NVTS $51.14
- P/E Ratio
- CVAC $6.35
- NVTS N/A
- Revenue Growth
- CVAC 787.60
- NVTS N/A
- 52 Week Low
- CVAC $2.37
- NVTS $1.52
- 52 Week High
- CVAC $5.72
- NVTS $9.48
- Technical
- Relative Strength Index (RSI)
- CVAC 60.60
- NVTS 50.38
- Support Level
- CVAC $5.41
- NVTS $6.51
- Resistance Level
- CVAC $5.54
- NVTS $7.56
- Average True Range (ATR)
- CVAC 0.05
- NVTS 0.65
- MACD
- CVAC -0.01
- NVTS -0.11
- Stochastic Oscillator
- CVAC 73.68
- NVTS 27.31
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.